Hogan Lovells

First published June 12th, 2018

As of 1 July 2018 an amended version of the self-regulatory Code of Conduct for Pharmaceutical Advertising (“CGR Code“) will become effective. The CGR Code contains provisions on pharmaceutical advertising and interactions between pharmaceutical companies and HCPs, including the disclosure of financial relations (Sunshine rules). The main changes in the CGR Code relate to:

  • the relationships between pharmaceutical companies and persons other than HCPs;
  • the specific conditions for sponsoring projects (grants/donations); and
  • hospitality at (scientific) meetings.

The reason for updating the CGR Code is the publication of the updated version of the policy rules inducement Medicines Act 2018 (“policy rules“) that became effective as of 1 April 2018. Consequently, the self-regulatory body CGR felt that further amendments to the CGR Code were necessary to align the CGR Code and the policy rules.

Read the full article here.